|
Subjects
|
Gender
|
Age of test (yrs)
|
Age of onset (yrs)
|
Systolic pressure (mmHg)
|
Diastolic pressure (mmHg)
|
IVST, mm(6-12 mm)
|
ECG
|
CCr (ml/min)
|
|---|
|
II-1
|
M
|
63
|
-
|
132
|
60
|
10
|
N
|
89.1
|
|
II-2*
|
F
|
60
|
50
|
160
|
80
|
12
|
LVH
|
81.2
|
|
II-3
|
M
|
61
|
-
|
128
|
68
|
11
|
N
|
102.8
|
|
II-4
|
F
|
58
|
-
|
120
|
60
|
10
|
N
|
103.5
|
|
II-5
|
M
|
68
|
-
|
124
|
58
|
9
|
N
|
87.9
|
|
II-6
|
F
|
62
|
-
|
130
|
60
|
10
|
N
|
86.5
|
|
II-7
|
M
|
70
|
-
|
132
|
70
|
10
|
N
|
92.6
|
|
II-8*
|
F
|
64
|
55
|
150
|
80
|
12
|
LVH
|
72.3
|
|
II-9
|
M
|
56
|
-
|
128
|
64
|
9
|
N
|
82.3
|
|
II-10
|
F
|
52
|
-
|
120
|
66
|
11
|
N
|
87.4
|
|
II-11
|
M
|
53
|
-
|
124
|
60
|
10
|
N
|
92.7
|
|
II-12
|
F
|
50
|
-
|
132
|
68
|
11
|
N
|
86.9
|
|
II-13*
|
M
|
54
|
48
|
140
|
100
|
11
|
N
|
83.2
|
|
II-14
|
F
|
50
|
-
|
128
|
60
|
9
|
N
|
119.2
|
|
III-1
|
M
|
40
|
-
|
130
|
60
|
8
|
N
|
122.3
|
|
III-2
|
M
|
38
|
-
|
128
|
58
|
8
|
N
|
130.2
|
|
III-3
|
F
|
35
|
-
|
118
|
60
|
9
|
N
|
118.6
|
|
III-4
|
M
|
33
|
-
|
120
|
58
|
9
|
N
|
108.6
|
|
III-5
|
M
|
40
|
40
|
150
|
90
|
12
|
N
|
89.1
|
|
III-6
|
M
|
39
|
-
|
124
|
60
|
9
|
N
|
121.3
|
|
III-7
|
F
|
44
|
43
|
160
|
90
|
13
|
LVH
|
71.2
|
|
III-8
|
M
|
30
|
-
|
116
|
60
|
8
|
N
|
114.5
|
|
III-9
|
F
|
28
|
-
|
128
|
70
|
9
|
N
|
134.8
|
|
III-10
|
M
|
28
|
-
|
126
|
70
|
9
|
N
|
107.9
|
|
III-11
|
M
|
25
|
-
|
130
|
70
|
10
|
N
|
126.7
|
|
III-12
|
F
|
27
|
-
|
120
|
58
|
9
|
N
|
139.6
|
- *These patients received antihypertension treatment. This table shows pretreatment blood pressures. CCr indicates endogenous creatinine clearance; F, female; M, male; IVST, interventricular septal thickness; LVH, ECG showed left ventricular hypertrophy; N, electrocardiography (ECG) was normal.
